PREMIER aims to deliver an innovative framework for characterising the environmental risks of active pharmaceutical ingredients (APIs), which can be used to: Develop tools and models to identify potential�environmental�hazards�and� risks associated with APIs earlier in drug development Screen and prioritise legacy APIs authorised for use prior to tailored environmental assessment Support the development of pharmaceuticals that are less harmful for the environment and promote greener manufacturing Make environmental data on APIs more visible and accessible to all stakeholders Learn more about the PREMIER project on our website.